Bionomics to Provide a Corporate Update and Discuss End-of-Phase 2 Meeting Outcomes on the Development of BNC210 in PTSD on July 31, 2024
Bionomics (BNOX) Newsfilter·2024-07-29 20:30Webcast Presentation: Click here General Rajeev Chandra Company Secretary CoSec@bionomics.com.au Investor Relations Kevin Gardner kgardner@lifesciadvisors.com Investor Relations Chris Calabrese ccalabrese@lifesciadvisors.com Conference Call and Webcast Presentation Date and Time: Wednesday, July 31, 2024 at 8:00 a.m. ET Toll Free: 1-877-407-0792 International: 1-201-689-8263 Conference ID: 13748183 FOR FURTHER INFORMATION PLEASE CONTACT: Bionomics (NASDAQ: BNOX) is a clinical-stage biotechnology company dev ...